[Federal Register Volume 71, Number 162 (Tuesday, August 22, 2006)]
[Notices]
[Page 48931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-13818]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Veterinary Medicine Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Veterinary Medicine Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 25, 2006, from 
8:30 a.m. to 5 p.m.
    Location: DoubleTree Hotel, Plaza Rooms II-III, 1750 Rockville 
Pike, Rockville, MD.
    Contact Person: Aleta Sindelar, Food and Drug Administration, 7519 
Standish Pl., Rockville, MD 20855, 240-276-9004, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 3014512548. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: The committee will discuss and make recommendations on the 
microbial food safety of an antimicrobial drug application currently 
under review for use in food-producing animals in accordance with the 
Center for Veterinary Medicine's guidance for industry 152.
    The background material for this meeting will be posted on the 
Internet no later than 1 business day before the meeting at http://www.fda.gov/cvm/default.html.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person on or before 
September 13, 2006. Oral presentations from the public will be 
scheduled between approximately 1 p.m. and 2 p.m. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their presentation 
on or before September 13, 2006.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Aleta Sindelar at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 16, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E6-13818 Filed 8-21-06; 8:45 am]
BILLING CODE 4160-01-S